Page last updated: 2024-11-05

trimetrexate and Neuroblastoma

trimetrexate has been researched along with Neuroblastoma in 2 studies

Trimetrexate: A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against PNEUMOCYSTIS PNEUMONIA in AIDS patients. Myelosuppression is its dose-limiting toxic effect.

Neuroblastoma: A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dasgupta, A1
Shields, JE1
Spencer, HT1
Pappo, AS1
Vats, T1
Williams, TE1
Bernstein, M1
Kamen, BA1

Trials

1 trial available for trimetrexate and Neuroblastoma

ArticleYear
Phase I trial of trimetrexate in pediatric solid tumors: a Pediatric Oncology Group study.
    Medical and pediatric oncology, 1993, Volume: 21, Issue:4

    Topics: Adolescent; Adult; Brain Neoplasms; Carcinoma, Renal Cell; Child; Child, Preschool; Female; Follow-U

1993

Other Studies

1 other study available for trimetrexate and Neuroblastoma

ArticleYear
Treatment of a solid tumor using engineered drug-resistant immunocompetent cells and cytotoxic chemotherapy.
    Human gene therapy, 2012, Volume: 23, Issue:7

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cell Survival; Coculture Techniq

2012